Other Current Liabilities - InterCure Ltd (NASDAQ:INCR) - Alpha Spread
I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 84.8m USD
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InterCure Ltd
Other Current Liabilities Peer Comparison

Comparables:
TEVA
RDHL
SLGL
MDWD
R
REKA

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
NASDAQ:INCR
Other Current Liabilities
â‚Ş4.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Other Current Liabilities
$5.2B
CAGR 3-Years
0%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
Redhill Biopharma Ltd
NASDAQ:RDHL
Other Current Liabilities
$15m
CAGR 3-Years
-17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sol Gel Technologies Ltd
NASDAQ:SLGL
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Other Current Liabilities
$19.9m
CAGR 3-Years
53%
CAGR 5-Years
27%
CAGR 10-Years
27%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Other Current Liabilities
â‚Ş9.5m
CAGR 3-Years
205%
CAGR 5-Years
135%
CAGR 10-Years
24%

See Also

What is InterCure Ltd's Other Current Liabilities?
Other Current Liabilities
4.1m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Other Current Liabilities amounts to 4.1m ILS.

What is InterCure Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 1Y
-60%

Over the last year, the Other Current Liabilities growth was -60%.

Back to Top